NIH-funded research R01 grant

Understanding how adrenaline affects brain functions and diseases

Official title: Adrenergic transmission properties and implication

Funded at University of Virginia · NIH-11054653 · Data updated 2026-11-12

This study is looking at how two important chemicals in the brain, norepinephrine and epinephrine, affect our thinking and attention, especially in people with conditions like Alzheimer's, to find new ways to help improve their symptoms.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startMarch 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$363,375
NIH project number5R01NS131670-03
Project IDNIH-11054653 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other neurological disorders associated with adrenergic transmission dysregulation.

Less likely to help

Patients with conditions unrelated to adrenergic transmission or those not diagnosed with neurological disorders may not benefit from this research.

What this research studies

This research investigates the role of norepinephrine and epinephrine in cognitive functions such as attention and sensory processing, as well as their impact on various neurological diseases, including Alzheimer's disease. The team has developed advanced sensors to visualize adrenergic transmission in real-time, allowing for a better understanding of how these neurotransmitters function in the brain and other organs. By studying these mechanisms, the research aims to uncover potential therapeutic targets for conditions linked to adrenergic dysregulation.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for neurological diseases like Alzheimer's and improve cognitive function in affected patients.

How similar studies have gone: Previous research has shown promising results in understanding adrenergic transmission, but this approach with advanced sensors is relatively novel.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Beenhakker, Mark — University of Virginia
  • Study coordinator: Beenhakker, Mark

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.